Section 4: Clinical Pharmacy Services 2022
DOI: 10.1136/ejhpharm-2022-eahp.133
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-104 Persistence with disease-modifying therapy in multiple sclerosis patients

Abstract: excellent if £5%. From 2016 to 2019 an audit was carried out annually, selecting a random sample of 30 patients and establishing an annual improvement plan according to the results (Table 1).The improvement proposals established for each year were: 2016, include a week rotation in the reconciliation area for the first-year resident; 2017, extend MR rotation of the thirdyear resident from 2 to 5 months; 2018, establish a supervision/review circuit by the reference pharmacist of the RRs performed.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles